Medbox, Inc. (MDBX), a leading licensing, infrastructure and security specialist, patented technology provider, and partner to the cannabis industry, today announced that under its new management team, the previously announced financial review has been completed.

The company said in a Form 8K filed today with the Securities and Exchange Commission, that in connection with the financial review, it plans to file an amended and restated Form 10 containing restated financial statements for the years ended December 31, 2012 and 2013, along with amended and restated Forms 10Q for the first, second and third quarters of 2014, later this month, at which time Medbox will be current with all of its public filings. The company also anticipates reporting financial results for the full 2014 year this month.

Management plans to conduct a conference call to discuss the results and the company’s growth strategy under its new leadership team following release of its full 2014 financial results.

Guy Marsala, who joined Medbox as president and chief executive officer in July 2014, said, “With the comprehensive financial review behind us, our management team will devote full attention on successfully implementing the company’s strategic plan and business model, helping a growing number of clients attain state license awards and providing ongoing support services.”

About Medbox, Inc.

Medbox is a leading dispensary and cultivation infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Medbox utilizes its expertise to work with investors and entrepreneurs who seek to enter the cannabis sector, providing them with a high quality turn-key solution, consisting of licensing, site selection, permitting, design, and full build-out. Medbox has become a leader in providing compliance, safety, security, oversight and operational expertise to the medical and recreational cannabis industry nationwide. For more information about the company, visit www.medbox.com.

Forward-Looking Statements

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, filing an amended and restated Form 10 and Form 10Qs for prior periods and reporting 2014 financial results in March, are based on current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, technical advances in the industry, as well as political and economic conditions present within the industry. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

For more information, contact:

Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com